Steven M Smith

Steven M Smith, PharmD, MPH, FCCP, FAHA

Associate Professor & Chair, Pharmaceutical Outcomes & Policy; Co-Director, Center For Integrative Cardiovascular And Metabolic Disease

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-5134
Business Email: ssmithm@ufl.edu

On This Page

About Steven M Smith

Steven Smith is an Associate Professor and Chair of the Department of Pharmaceutical Outcomes and Policy, with a courtesy appointment in the Division of Cardiovascular Medicine (College of Medicine). He also serves as Co-Director for the UF Center for Integrative Cardiovascular and Metabolic Diseases.

He received his PharmD degree from the University of Florida College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine during which time he participated in the Advanced Postgraduate Program in Clinical Investigation (APPCI) and concurrently completed the requirements for a Master of Public Health. Dr. Smith joined the faculty at the University of Colorado in 2011. He returned to the University of Florida in 2014.

Dr. Smith’s research is in the area of cardiovascular pharmacotherapy, in particular hypertension and cardiometabolic disease, and is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the U.S. Department of Defense. He is an elected Fellow in the American Heart Association and the American College of Clinical Pharmacy, as well as a member of the American College of Cardiology, American Association of Colleges of Pharmacy and the International Society for Pharmacoepidemiology. He also has served in several leadership roles nationally, including on the Examination Committee for the American Society of Hypertension Specialists’ Program (ASHSP) Certified Hypertension Clinician program, in several initiatives through the American Heart Association Hypertension Council, on the Board of Directors for the Consortium for Southeastern Hypertension Control (2019-2023 term), and as a founding member of the CDC’s National Hypertension Control Roundtable.

Dr. Smith co-coordinates a graduate course on Measurement in Pharmaceutical Outcomes Research.

From 2014 to 2023, Dr. Smith also co-directed the UF Family Medicine Pharmacy Fellowship.

Related Links:

Accomplishments

  1. Fellow

    American Heart Association

  2. Teaching and Service Excellence Award

    University of Florida College of Pharmacy

  3. Excellence Award for Assistant Professors

    University of Florida

  4. Fellow

    American College of Clinical Pharmacy

  5. Delta Omega Inductee

    University of Florida College of Public Health & Health Professions

  6. Teaching and Service Excellence Award

    University of Florida College of Pharmacy

  7. New Investigator Award

    American College of Clinical Pharmacy

  8. Anniversary Fellow in Pharmacy

    National Academy of Medicine

Teaching Profile

Courses Taught

  1. PHA5007 – Pharm and Pop Health

    College of Pharmacy

  2. PHA5788 – Pharmacotherapy 6

    College of Pharmacy

  3. PHA5788C – Patient Care 6

    College of Pharmacy

  4. PHA7979 – Advanced Research

    College of Pharmacy

  5. PHA6265 – Introduction to Pharmaceutical Outcomes and Policy I

    College of Pharmacy

  6. PHA6910 – Supervised Research

    College of Pharmacy

  7. PHA7980 – Research for Doctoral Dissertation

    College of Pharmacy

  8. PHA6946 – Practicum in the Pharmaceutical Sciences

    College of Pharmacy

  9. PHA5223 – P-Epidem Drug Safety

    College of Pharmacy

  10. PHA6717 – Measurement in Pharmaceutical Outcomes and Policy Research

    College of Pharmacy

Board Certifications

  • Board-Certified Pharmacotherapy Specialist
    Board of Pharmaceutical Specialties
  • Certified Hypertension Clinician
    American Hypertension Specialist Certification Program

Research Profile

Dr. Smith’s research lab focuses on understanding and improving use of cardiovascular-related drug therapy in the real world to reduce risk of major adverse outcomes at the population level. Hypertension and its treatment are the major area of focus, and Dr. Smith has particular expertise in the area of difficult-to-control, or ‘resistant’ hypertension.

His lab employs a variety of observational methodologic approaches and data sources, including EHR, administrative claims, and prospective cohort and randomized clinical trial data. Strong collaborations within the College of Pharmacy include with faculty and trainees in the Cardiovascular group of the Department of Pharmaceutical Outcomes and Policy and the Center for Drug Evaluation and Safety as well as with the Department of Pharmacotherapy and Translational Research. Outside of the College, Dr. Smith’s group works closely with the Division of Cardiovascular Medicine and the Center for Integrative Cardiovascular and Metabolic Diseases, where Dr. Smith serves as Co-Director.

Current funding for the lab is through the National Heart, Lung and Blood Institute (studying minocycline as a treatment for resistant hypertension; what drives antihypertensive prescribing and how to optimize early therapy; antihypertensive prescribing cascades; and, studying apparent treatment-resistant hypertension in the All-of-Us program), PCORI (hypertension surveillance through the BP Control Lab), and the U.S. Department of Defense (the WARRIOR trial).

Areas of Interest

  • Cardiometabolic Disease
  • Cardiovascular Epidemiology
  • Hypertension
  • Pharmacoepidemiology
  • Resistant Hypertension

Publications

Academic Articles

Grants

  1. Analyzing effectiveness of ongoing natural experiments in telehealth

    Active

    Role:
    Principal Investigator
    Funding:
    NATL INST OF HLTH NHLBI
  2. Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis

    Active

    Role:
    Principal Investigator
    Funding:
    NATL INST OF HLTH NHLBI
  3. Hypertension Prediction and Identification in All of Us

    Active

    Role:
    Co-Investigator
    Funding:
    NATL INST OF HLTH NHLBI
  4. Real-World Trajectories of Xanthine Oxidase Inhibitor Use and Downstream Cardiovascular Outcomes

    Role:
    Other
    Funding:
    AMER HEART ASSOCIATION
  5. High-throughput screening for antihypertensive prescribing cascades

    Role:
    Principal Investigator
    Funding:
    NATL INST OF HLTH NHLBI
  6. Using PCORnet to Compare Blood Pressure Control Strategies

    Role:
    Co-Investigator
    Funding:
    UNIV OF CALIFORNIA SAN FRANCISCO via PATIENT-CENTERED OUTCOMES RES INST
  7. Advancing Personalized Hypertension Care through Big Data Science

    Role:
    Principal Investigator
    Funding:
    NATL INST OF HLTH NHLBI
  8. Women’s Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)

    Role:
    Co-Investigator
    Funding:
    US ARMY MED RES ACQUISITION
  9. Clinical and Translational Science Institute (CTSI)

    Role:
    Project Manager
    Funding:
    UF DIV OF SPONSORED RES MATCHING FUNDS
  10. Institute of Medicine Anniversary Fellow in Pharmacy

    Role:
    Principal Investigator
    Funding:
    NATL ACAD OF SCIENCES

Education

  1. Graduate Certificate in Biomedical Informatics

    University of Florida

  2. M.P.H.

    University of Florida

  3. Postdoctoral Fellow

    University of Florida

  4. Pharmacy Practice Residency

    NF/SG Veterans Affairs Health System, Gainesville, FL

  5. Pharm.D.

    University of Florida

Contact Details

Phones:
Business:
(352) 273-5134
Emails:
Business:
ssmithm@ufl.edu
Administrative Assistant II:
Gabrielle Gele
View Profile
Addresses:
Business Mailing:
PO Box 100496
GAINESVILLE FL 32610
Business Street:
1889 MUSEUM RD STE 6300
DSIT BLDG
GAINESVILLE FL 32611